Risk factors for chest wall recurrence include primary tumor size, primary stage, and lymph node involvement. In a study of 1031 patients by Katz et al., authors found that patients with tumors greater than or equal to 4 cm or at least 4 involved nodes experience local recurrence rates more than 20% HER2), and estrogen receptor status